Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson’s Foundation Elects Howard D. Morgan Chairman of the Board

MIAMI & NEW YORK — June 26, 2018 — The Parkinson’s Foundation today announced the election of Howard D. Morgan as chairman of its board of directors. Mr. Morgan, who previously served as the Vice Chair of the nonprofit organization’s board, is a Partner and the Senior Managing Director of Argand Partners in New York.

“Parkinson’s Foundation gains an impassioned and proven leader with Howard Morgan as Chairman who will ensure we further our mission to make life better for people with Parkinson’s disease,” said outgoing board chairman John W. Kozyak, Esq., who will remain on the board. “Howard’s appointment marks a new chapter for the Foundation, which has been on a strong growth trajectory over the last few years. That is expected to accelerate with Howard as chairman of the board.”

Mr. Morgan, who has been active in private equity for more than 30 years, also has served as a board member of more than 20 businesses in the U.S., Europe and Australia. He currently serves on the boards of Industrea Acquisition Corp.; Oase Living Water; Harvard Business School Club of New York; Alexander Hamilton Institute; World Press Institute; and Friends of the Garvan Institute of Medical Research.

“I am honored to further my commitment to the Parkinson’s community and the Foundation by building on the success of my predecessor John Kozyak during his tenure as chairman of the Parkinson’s Foundation,” Morgan said. “The Foundation’s mission is personal for me, as my father lived with the disease for many years.  I look forward to working with Andrew Albert as Vice Chair and the board to ensure a better life for everyone with Parkinson’s through investments in innovative research, improved clinical care, and expanded educational resources.”

Added Parkinson’s Foundation President and CEO John Lehr: “Howard is a proven leader with extensive business knowledge and experience.  He has been an invaluable contributor to our board for more than a decade, working closely with John Kozyak and other board members to position the Foundation for its current phase of rapid growth. We are thrilled Howard is taking on this critical role as the Foundation expands its mission programs for greater impact on all those living with and affected by Parkinson’s disease.”

Established in 1957, the Parkinson’s Foundation has headquarters in New York and Miami with more than 100 staff members across the country and has an annual budget of $30 million. In addition to supporting Parkinson’s research and patient and caregiver education, the Foundation has a national and international network of over 40 Parkinson’s Centers of Excellence at hospitals and academic medical institutions, where medical teams who specialize in Parkinson’s disease work together to treat and set the highest standards of care for people living with Parkinson’s.

Officers of the 27-person board are effective July 1, 2018: Howard D. Morgan, Chair; Andrew B. Albert, Vice Chair; Constance W. Atwell, PhD, Secretary; Curt DeGreff, Assistant Secretary; Stephen Ackerman, Treasurer; J. Gordon Beckham, Jr., Assistant Treasurer; Kelly Sweeney, Chair, People with Parkinson’s Advisory Council. A complete list of the Parkinson’s Foundation’s board of directors is available at www.parkinson.org/board.

About the Parkinson’s Foundation 
The Parkinson’s Foundation makes life better for people with Parkinson’s disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience and passion of our global Parkinson’s community. For more information, visit www.parkinson.org or call (800) 4PD-INFO (473-4636).

About Parkinson’s Disease 
Affecting nearly one million Americans and 10 million worldwide, Parkinson’s disease is the second-most common neurodegenerative disease after Alzheimer’s and is the 14th-leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression), as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for Parkinson’s and 60,000 new cases are diagnosed each year in the United States alone.

 
Tuesday, June 26, 2018
New Study Shows 1.2 Million People in the United States Estimated to be Living with Parkinson’s Disease by 2030
Tuesday, July 10, 2018

Parkinson’s Foundation Reveals Most Comprehensive Estimate of
Parkinson’s Prevalence in North America since the 1970’s

Parkinson’s Foundation Elects Howard D. Morgan Chairman of the Board
Tuesday, June 26, 2018

MIAMI & NEW YORK — June 26, 2018 — The Parkinson’s Foundation today announced the election of Howard D. Morgan as chairman of its board of directors. Mr. Morgan, who previously served as the Vice Chair of the nonprofit organization’s board, is a Partner and the Senior Managing Director of Argand Partners in New York.

Parkinson’s Foundation Announces Five New Members of its People with Parkinson’s Advisory Council
Wednesday, June 13, 2018

NEW YORK & MIAMI — June 13, 2018 — The Parkinson’s Foundation today announced five new members of its People with Parkinson’s Advisory Council.

The Parkinson’s Foundation 2018 Gala in New York City Tuesday, May 8, 2018
Monday, May 14, 2018

The Parkinson’s Foundation 2018 Gala was held at Cipriani 25 Broadway in New York City on Tuesday, May 8, 2018.

Parkinson’s Foundation Adds Alison Herman to its Board of Directors
Tuesday, May 8, 2018

MIAMI – May 9, 2018 – The Parkinson’s Foundation today announced the election of Alison Herman to its board of directors. Herman is senior counsel at Southern Glazer’s Wine & Spirits, a company which has generously supported Parkinson’s Foundation fundraisers.

Statement on Nuplazid Drug
Tuesday, April 10, 2018

On 4/9/18, CNN published an article on the FDA-approved drug, Nuplazid, used to treat hallucinations and psychosis in Parkinson’s disease. The article investigates FDA data showing the number of reported deaths with people taking Nuplazid. Nuplazid was approved by the FDA in 2016 and is manufactured by Acadia Pharmaceuticals.

Parkinson’s Foundation Adds John D. Thomopoulos to its Board of Directors
Monday, March 19, 2018

MIAMI & NEW YORK – March 19, 2018 – The Parkinson’s Foundation today announced the election of John D. Thomopoulos to its board of directors. Thomopoulos is a partner at Ernst & Young.

In Memory of Edythe Kay Marsa
Monday, March 12, 2018

The Parkinson’s Foundation mourns the loss of emeritus board member, Edythe (Edy) Kay Marsa. From 1993 to 2014, she was a member of the Foundation’s board of directors and served on several committees. Edy is survived by her husband William Marsa, who founded the Herbert Kay Parkinson Chapter in honor of her first husband who passed away due to complications from Parkinson’s disease.

Parkinson’s Foundation Announces New Genetic Initiative Connecting Parkinson’s Genetic Data with Clinical Care
Tuesday, March 6, 2018

MIAMI & NEW YORK—March 6, 2018—The Parkinson’s Foundation today announced a new initiative offering genetic testing and counseling to Parkinson’s patients within its Center of Excellence network.

Delegates From The Parkinson’s Community Converge On Capitol Hill To Advocate For Critical Research Funding
Monday, March 5, 2018

—2018 Parkinson’s Policy Forum Co-Sponsored by the Parkinson’s Foundation and the Michael J. Fox Foundation for Parkinson’s Research—

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.